Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000040365 | SCV000064056 | uncertain significance | not specified | 2012-02-23 | criteria provided, single submitter | clinical testing | The Gly1570Ala variant (TTN) has been identified in 3/3738 African American chro mosomes from a broad population by the NHBLI Exome Sequencing Project (http://ev s.gs.washington.edu/EVS). Glycine (Gly) at position 1570 is highly conserved in mammals and across evolutionarily distant species, though computational analyses (biochemical amino acid properties, AlignGVGD, and SIFT) do not provide strong support for or against an impact to the protein. Additional information is neede d to fully assess the clinical significance of the Gly1570Ala variant. |
Gene |
RCV001719773 | SCV000715769 | likely benign | not provided | 2021-01-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002336142 | SCV002636996 | likely benign | Cardiovascular phenotype | 2020-09-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Revvity Omics, |
RCV001719773 | SCV003819647 | uncertain significance | not provided | 2020-02-12 | criteria provided, single submitter | clinical testing |